title: Unexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes.
abstract: Activators of protease-activated receptors PAR-1 and PAR-2 such as thrombin and synthetic hexapeptides promote hypertrophy of isolated neonatal cardiomyocytes at pathological concentrations. Since PAR-activating proteases often show dual actions at low vs. high concentrations, the potential hypertrophic effects of low-level PAR activation were examined. In H9c2 cardiomyoblasts, messenger RNA (mRNA) expression of the hypertrophic marker atrial natriuretic peptide (ANP) was significantly increased only by higher concentrations of thrombin, trypsin or the synthetic PAR-2 agonist SLIGRL. The dual PAR-1/PAR-2 agonist SFLLRN did not influence basal ANP mRNA expression in H9c2 cells. Low concentration of thrombin or trypsin (up to 0.1 U/mL) or of the synthetic ligands SFLLRN and SLIGRL (1 μM); however, all suppressed ANP mRNA expression stimulated by angiotensin II (Ang II). The PAR-1 selective ligand TFLLRN exerted a comparable effect as SFLLRN. In adult rat cardiomyocytes, protein synthesis determined by [(3)H]phenylalanine incorporation was not increased by various PAR agonists at concentrations tenfold lower than conventionally used to study PAR function in vitro (10 μM for SFLLRN or SLIGRL, 0.1 U/mL for thrombin or trypsin). The positive control endothelin-1 (ET-1, 60 nM) however significantly increased protein synthesis in adult rat cardiomyocytes. Addition of low concentrations of PAR agonists to cardiomyocytes treated with ET-1 or Ang II suppressed [(3)H]phenylalanine incorporation induced by the hypertrophic stimuli. The inhibitory effect of SFLLRN effect was partially reversed by the PAR-1 antagonist RWJ56110. These findings suggest that physiological concentrations of PAR activators may suppress hypertrophy, in contrast to the pro-hypertrophic effects evident at high concentrations. PAR-1 and PAR-2 may dynamically control cardiomyocyte growth, with the net effect critically dependent upon local agonist concentrations. The precise significance of proposed concept of bimodal PAR function in cardiomyocytes remains to be defined, particularly in vivo where hemodynamic and other regulatory factors may counteract or mask the direct cellular actions described here.
authors.affiliation: Institut für Pharmakologie and Klinische Pharmakologie, Universitätsklinikum der Heinrich-Heine-Universität, Moorenstraße 5, 40225, Düsseldorf, Germany, anke.fender@uni-duesseldorf.de.
authors.forename: Anke C
authors.initials: AC
authors.lastname: Fender
authors.forename: Goran
authors.initials: G
authors.lastname: Pavic
authors.forename: Grant R
authors.initials: GR
authors.lastname: Drummond
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Dusting
authors.forename: Rebecca H
authors.initials: RH
authors.lastname: Ritchie
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D049108:Cell Enlargement / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006984:Hypertrophy / Q000378:metabolism / Q000517:prevention & control; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D044463:Receptor, PAR-1 / Q000819:agonists / Q000378:metabolism*; D044464:Receptor, PAR-2 / Q000819:agonists / Q000378:metabolism*; D013552:Swine; D013917:Thrombin / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D044463:Receptor, PAR-1; D044464:Receptor, PAR-2; D000804:Angiotensin II; D013917:Thrombin
references.citation: J Surg Res. 2001 Oct;100(2):154-60
references.pmid: 11592785
references.citation: J Biol Chem. 1993 Sep 25;268(27):20646-52
references.pmid: 8397212
references.citation: Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2264-9
references.pmid: 10681455
references.citation: Pharmacol Ther. 2009 Dec;124(3):279-300
references.pmid: 19723539
references.citation: Annu Rev Physiol. 2003;65:45-79
references.pmid: 12524460
references.citation: Am J Physiol. 1993 Feb;264(2 Pt 2):H573-82
references.pmid: 8447469
references.citation: Circ Res. 1999 Feb 5;84(2):136-45
references.pmid: 9933244
references.citation: FASEB J. 1999;13 Suppl:S17-22
references.pmid: 10352141
references.citation: Diabetes. 2003 Sep;52(9):2389-95
references.pmid: 12941780
references.citation: J Mol Cell Cardiol. 2000 Jun;32(6):1119-26
references.pmid: 10888262
references.citation: Nature. 2000 Sep 14;407(6801):258-64
references.pmid: 11001069
references.citation: Circ Res. 2000 May 26;86(10):1054-61
references.pmid: 10827135
references.citation: Blood. 2000 May 15;95(10):3133-8
references.pmid: 10807779
references.citation: J Biol Chem. 2003 Mar 28;278(13):11714-20
references.pmid: 12522105
references.citation: J Cell Mol Med. 2005 Jul-Sep;9(3):704-13
references.pmid: 16202218
references.citation: Pharmacol Rev. 2001 Jun;53(2):245-82
references.pmid: 11356985
references.citation: J Orthop Res. 2006 Mar;24(3):508-15
references.pmid: 16453341
references.citation: J Cell Physiol. 2009 Jun;219(3):744-51
references.pmid: 19189342
references.citation: Am J Pathol. 2000 Apr;156(4):1217-25
references.pmid: 10751347
references.citation: Ann N Y Acad Sci. 2006 Oct;1080:154-64
references.pmid: 17132782
references.citation: Comp Biochem Physiol A Mol Integr Physiol. 2002 Aug;132(4):691-8
references.pmid: 12095856
references.citation: Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2430-6
references.pmid: 9409212
references.citation: Thromb Haemost. 2011 Sep;106(3):561-2
references.pmid: 21800011
references.citation: J Cereb Blood Flow Metab. 2002 Apr;22(4):404-10
references.pmid: 11919511
references.citation: Am J Physiol. 1998 Oct;275(4):H1370-4
references.pmid: 9746487
references.citation: Circulation. 2007 Nov 13;116(20):2298-306
references.pmid: 17967980
references.citation: Circ Res. 2002 Sep 20;91(6):532-9
references.pmid: 12242272
references.citation: Diabetologia. 2012 Dec;55(12):3369-81
references.pmid: 23001375
references.citation: J Clin Invest. 1992 Mar;89(3):939-46
references.pmid: 1531837
references.citation: IUBMB Life. 2011 Jun;63(6):383-9
references.pmid: 21438116
references.citation: Basic Res Cardiol. 2007 Jul;102(4):350-8
references.pmid: 17468933
references.citation: J Biol Chem. 1996 Jun 14;271(24):13943-7
references.pmid: 8662993
references.citation: Biochem Soc Trans. 2007 Nov;35(Pt 5):957-61
references.pmid: 17956254
references.citation: Am J Pathol. 2000 Dec;157(6):1849-62
references.pmid: 11106558
references.citation: Cell Signal. 1998 Nov;10(10):693-8
references.pmid: 9884020
references.citation: Mt Sinai J Med. 2006 Oct;73(6):840-51
references.pmid: 17117309
references.citation: Inflamm Res. 2004 Mar;53 Suppl 1:S17-8
references.pmid: 15054598